Alterity Therapeutics Limited - Depositary Receipt (Common Stock) (ATHE) at a glance

Alterity Therapeutics Limited - Depositary Receipt (Common Stock) (ATHE) is a micro-cap Healthcare company. It trades at $4.74, with a -219.9% profit margin and revenue growth of 74.6%. It does not pay a dividend. Vestovix scores it 55/100 overall. Its strongest dimension is Safety (86/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$4.74

Market cap

$76.3M

P/E ratio

n/a

Dividend yield

None

Beta

-0.01

52-week range

$2.66 to $7.00